key: cord-0789808-kjt339pi authors: Servato, María L.; Valente, Filipa X.; García-Moreno, Laura Gutiérrez; Casas, Guillem; Fernández-Galera, Rubén; Burcet, Gemma; Teixidó-Tura, Gisela; Calabria, Hug Cuéllar; González, Ignacio Ferreira; Rodríguez-Palomares, José F. title: Intraventricular Conundrum in a SARS-CoV-2–Positive Patient With Elevated Biomarkers of Myocardial Injury date: 2021-03-31 journal: JACC Case Rep DOI: 10.1016/j.jaccas.2021.01.030 sha: e0ffd8e52e47682084fc4ab0985be14940edc1b7 doc_id: 789808 cord_uid: kjt339pi We present a case of acute myocarditis with left ventricular dysfunction and intracavitary thrombosis in a 55-year-old man with severe acute respiratory syndrome coronavirus 2 infection (coronavirus disease 2019) who was admitted with bilateral atypical pneumonia. The patient was treated with anticoagulation and optimal heart failure therapy and had an improvement of left ventricular function and thrombus resolution. (Level of Difficulty: Intermediate.) to maintain a peripheral oxygen saturation of 96%. However, 3 days after hospitalization, D-dimer levels increased significantly (up to 12,835 ng/ml), as did troponin I and NT-proBNP levels ( Given the patient's clinical presentation with LV dysfunction, the differential diagnosis included ischemic cardiomyopathy, myocarditis, and decompensation of a previously unknown cardiomyopathy. Because of the presence of a huge intraventricular mass, thrombus versus intracardiac tumor was proposed. Moreover, recent biopsy data revealed that T 1 and T 2 increase in this population is related to myocarditis (lymphocytic infiltrates) (7) . Although the presence of elevated troponin I is frequently seen in patients with myocarditis and is usually associated with myocyte necrosis, our patient had elevated troponin but no late gadolinium enhancement. We believe that these findings can be To the best of our knowledge, no similar case has been published. The patient was discharged in good clinical condition. He is currently receiving the following Late gadolinium enhancement images in the 2-chamber (left) and mid-short-axis views (right) with no evidence of focal necrosis or fibrosis. Nevertheless, there is diffuse mild hyperintensity of the middle and apical anterior wall (arrows). This is a rare case of myocarditis with acute LV thrombosis and dysfunction in a young patient with The European Society for Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic Pathological findings of COVID-19 associated with acute respiratory distress syndrome Potential effects of coronaviruses on the cardiovascular system. A review High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study The hypercoagulable state in COVID-19: incidence, pathophysiology, and management COVID-19 and simultaneous thrombosis of two coronary arteries Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations First case of COVID-19 complicated with fulminant myocarditis: a case report and insights COVID-19, and echocardiography KEY WORDS cardiovascular magnetic resonance (CMR), computed tomography, COVID-19, echocardiography, myocarditis, thrombus APPENDIX For supplemental videos, please see the online version of this article Intraventricular Conundrum in a SARS-CoV-2 Patient The authors have reported that they have no relationships relevant to the contents of this paper to disclose.